SC-CAR.GPC3xIL15.21 CAR T cells: Clinical Trials

2 trials of SC-CAR.GPC3xIL15.21 CAR T cells, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 recruiting. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Not yet recruiting 1, Recruiting 1

Follow SC-CAR.GPC3xIL15.21 CAR T cells: new trials by email Literature Review of SC-CAR.GPC3xIL15.21 CAR T cells trials Research Report on SC-CAR.GPC3xIL15.21 CAR T cells

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cytokine Armored GPC3 Specific Chimeric Antigen Receptor Expressing T-cells in Adults With Solid Tumors
SC-CAR.GPC3xIL15.21 CAR T cells - Solid Tumor (Excluding CNS), Hepatocellular Carcinoma
Phase 1Not yet recruitingSeattle Children's Hospital212026-04-012025-11-04
Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
SC-CAR.GPC3xIL15.21 CAR T cells - Solid Tumor (Excluding CNS), Liver Cell Carcinoma
Phase 1RecruitingSeattle Children's Hospital212025-12-222026-02-17

Conditions studied

Carcinoma, Hepatocellular (2)  ·  Endodermal Sinus Tumor (2)  ·  Liposarcoma (2)  ·  Liver Neoplasms (2)  ·  Rhabdomyosarcoma (2)  ·  Hepatoblastoma (1)  ·  Rhabdoid Tumor (1)  ·  Wilms Tumor (1)

Sponsors

Seattle Children's Hospital (2)

Countries

United States (2)

Top investigators

Colleen Annesley (1)  ·  Colleen Annesley, MD (1)  ·  Corinne Summers (1)  ·  Corinne Summers, MD (1)